GuiDeCode

CIWA-Ar

Clinical Institute Withdrawal Assessment for Alcohol — revised

Calculator

Loading calculator…

Why use it

Standardizes alcohol withdrawal assessment. Enables symptom-triggered therapy (reduces total benzodiazepine use vs. fixed-dose schedules). Identifies patients at risk for severe withdrawal and delirium tremens.

About

The CIWA-Ar is a 10-item assessment tool used to quantify the severity of alcohol withdrawal and guide symptom-triggered benzodiazepine therapy. It evaluates nausea/vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile/auditory/visual disturbances, headache, and orientation. Scores guide dosing of benzodiazepines (typically chlordiazepoxide, lorazepam, or diazepam).

When to use

  • Suspected or confirmed alcohol withdrawal
  • Inpatient monitoring of alcohol withdrawal every 1-4 hours
  • Guiding benzodiazepine dosing in withdrawal protocols

Formula

Sum of 10 items (0-7 each, except orientation 0-4): Nausea/Vomiting (0-7), Tremor (0-7), Paroxysmal Sweats (0-7), Anxiety (0-7), Agitation (0-7), Tactile disturbances (0-7), Auditory disturbances (0-7), Visual disturbances (0-7), Headache (0-7), Orientation/clouding (0-4) Total: 0-67

Pearls & pitfalls

  • Symptom-triggered therapy (give benzos only when CIWA ≥ 10) is preferred over fixed-dose schedules.
  • Assess CIWA every 1-4 hours during active withdrawal; increase frequency if scores rising.
  • CIWA cannot be reliably used in intubated, sedated, or severely altered patients.
  • Peak withdrawal typically occurs 24-72 hours after last drink; delirium tremens at 48-96 hours.
  • Seizures can occur before CIWA scores are high — maintain clinical vigilance.
  • Consider thiamine (100-500 mg IV) and folate supplementation in all alcohol withdrawal patients.

Next steps

Score < 10: Mild withdrawal, may not require medication. Score 10-18: Moderate withdrawal, initiate symptom-triggered benzodiazepines. Score > 20: Severe withdrawal, higher doses, consider ICU. Score > 35: Risk of seizures and delirium tremens, aggressive treatment.

Evidence

Developed by Sullivan et al. (Br J Addiction, 1989). Extensively validated. Symptom-triggered therapy shown to reduce treatment duration, total benzodiazepine dose, and ICU admissions (Saitz et al., JAMA 1994).

References

  1. Sullivan JT et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addiction. 1989;84(11):1353-1357. — link
  2. Saitz R et al. Individualized treatment for alcohol withdrawal. JAMA. 1994;272(7):519-523. — link